|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation, amortization and accretion expense | |||||
| Amortization of deferred financing costs | |||||
| Credit loss expense | |||||
| Deferred income tax (benefit) expense | |||||
| Equity-based employee and director compensation expense | |||||
| Gain on dispositions and lease terminations, net | |||||
| Changes in operating assets and liabilities, net of acquisitions | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Principal payments received on notes receivable | |||||
| Proceeds from sale of assets | |||||
| Capital expenditures | |||||
| Lease termination payments to Applegreen, including inventory purchases | |||||
| Net cash provided by (used in) investing activities | |||||
| Cash flows from financing activities: | |||||
| Borrowings under the Credit Facility | |||||
| Repayments on the Credit Facility | |||||
| Repayments on the Term Loan Facility | |||||
| Payments of finance lease obligations | |||||
| Payments of deferred financing costs | |||||
| Distributions paid on distribution equivalent rights | |||||
| Income tax distributions paid on preferred membership interests | |||||
| Distributions paid on common units | |||||
| Net cash used in financing activities | |||||
| Net decrease in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...